What You Should Know:
- Cerner, Elligo Health Research® and Freenome are collaborating to enable a clinical trial through the Learning Health Network to help advance early cancer detection.
- Together they will be using the research-activated network of health systems, real-world data (RWD) and multiomics technology, developed by Freenome, with the goal to help accelerate early cancer detection.
Importance of Early Cancer Detection
Early
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
HealthQuest Capital Closes $675M for Fund IV to Invest in Transformational Healthcare Companies
What You Should Know:
- HealthQuest Capital, a sector specialist capital firm focused on companies optimizing value in healthcare, today announced the close of HealthQuest Partners IV, L.P., at its hard cap of $675M .
- The oversubscribed fund will enable HealthQuest to continue to invest in growth-stage companies that are revolutionizing the healthcare industry.
Providing Growth Capital to Companies Transforming Healthcare
Founded in 2013 by Garheng Kong, a physician, scientist, and
Read More
Delivering Patient-Centered Care Means Decluttering the Digital Health Landscape
Digital health companies (DHCs) and their solutions continue to grow at a rapid pace. This is in part being fueled by the record funding for DHCs, with over $29 billion for US-based companies in 2021 alone. As a result, patients are inundated with solutions from every direction – from employers, health plans, and directly through consumer-oriented apps and wearables. Physicians are also getting into the mix by directly prescribing digital therapeutics. On the surface, the blossoming of the
Read More
OncoHost Raises $35M for AI-Powered Precision Oncology Platform
What You Should Know:
- OncoHost, an AI-powered precision oncology platform, today announced a $35M Series C funding round led by ALIVE Israel HealthTech VC, as well as other prominent investors. Additional investors included leading Israeli financial firm Leumi Partners, Israel’s largest pension fund Menora Mivtachim, OurCrowd and other existing investors.
- The funding will go towards expanding OncoHost’s ongoing multicenter PROPHETIC trial as well as support its upcoming
Read More
Kelonia Therapeutics Emerges with $50M to Deliver Precision Targeted Genetic Medicines
What You Should Know:
- Kelonia Therapeutics, a Boston-based biotech company focused on vivo gene delivery, launched with a $50 million in Series A funding to expand the benefit and reach of genetic medicines.
- Despite life-changing responses, existing gene therapies are highly complex, costly, and limited by complicated treatment paradigms, tractable therapeutic applications, and dose-limiting toxicities. By enabling precisely targeted, highly efficient, manufacturable “off-the-shelf” in
Read More
Mayo Clinic Partners with VUNO to Develop AI-Driven Precision Oncology Solutions
What You Should Know:
- Mayo Clinic has signed a research agreement with VUNO, a global medical artificial intelligence (AI) company to develop advanced AI-driven precision oncology solutions to deliver precision oncology care.
- Through this research agreement, VUNO will establish a collaboration with Mayo Clinic to develop innovative AI and machine learning solutions for more precise diagnosis, prognosis and treatment stratification in cancer.
- This collaborative agreement combines
Read More
Using NLP Technology To Uncover Real-World Patient Insights
It’s estimated that humans create a combined 2.5 quintillion bytes of data each day – and that around 90% of all data to ever exist was created in just the last few years. As difficult as it is to ignore the massive impact that connected technologies and social media have had on the way we experience our world, it’s somehow even more challenging to fully grasp the scale of it. For health researchers, this data explosion – and especially the rise
Read More
Transcarent Launches Oncology Care for Collaborative Cancer Care Experience
What You Should Know:
- Transcarent, a new, different, and better health and care experience company for employees of self-insured employers and their families launches Transcarent Oncology Care, a collaborative cancer care experience that connects employees and their families with high-quality cancer care from leading cancer institutes, top-rated oncology providers and researchers, and clinical trial identification irrespective of their geographic location.
- Transcarent Oncology Care
Read More
NCODA & XIFIN Launch Initiative to Expand Oncology Patient Care Options
What You Should Know:
- XIFIN has partnered with NCODA, Inc., a globally recognized association that develops unique resources to help medically integrated oncology teams deliver top-tier care. This new strategic partnership “NCODA Informatics Initiative Powered by VisualStrata” provides the use of VisualStrata as part of the NCODA membership.
- As oncology groups work to find and secure clinical trials – thereby expanding patient care options within their practice – purpose-built
Read More
PathAI and GlaxoSmithKline Partner to Accelerate Research and Drug Development
What You Should Know:
- PathAI and GSK announced a multi-year strategic artificial intelligence (AI) partnership today with a focus on accelerating research and- building drug development programs in oncology and non-alcoholic steatohepatitis (NASH).
- As part of the partnership, GSK will leverage both PathAI’s expertise and models to advance GSK’s proprietary AI models and focus on designing better models to deliver improved treatment options for patients with cancer
Read More
